Abbott Laboratories (ABL.DE)

EUR 108.8

(1.25%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 73.21 Billion 74.43 Billion 75.19 Billion 72.54 Billion 67.88 Billion 67.17 Billion
Total Current Assets 22.67 Billion 25.22 Billion 24.23 Billion 20.44 Billion 15.66 Billion 14.63 Billion
Cash And Short Term Investments 7.27 Billion 10.17 Billion 10.24 Billion 7.14 Billion 4.14 Billion 4.08 Billion
Cash and Cash Equivalents 6.89 Billion 9.88 Billion 9.79 Billion 6.83 Billion 3.86 Billion 3.84 Billion
Short Term Investments 383 Million 288 Million 450 Million 310 Million 280 Million 242 Million
Net Receivables 8.82 Billion 8.88 Billion 6.48 Billion 6.41 Billion 5.42 Billion 5.18 Billion
Inventory 6.57 Billion 6.17 Billion 5.15 Billion 5.01 Billion 4.31 Billion 3.79 Billion
Other Current Assets 2.25 Billion 2.66 Billion 2.34 Billion 1.86 Billion 1.78 Billion 1.56 Billion
Total Non-Current Assets 50.54 Billion 49.21 Billion 50.95 Billion 52.1 Billion 52.22 Billion 52.54 Billion
Net PPE 10.15 Billion 9.16 Billion 8.95 Billion 9.02 Billion 8.03 Billion 7.56 Billion
Good Will And Intangible Assets 32.49 Billion 33.25 Billion 35.97 Billion 38.52 Billion 40.22 Billion 42.19 Billion
Good Will 23.67 Billion 22.79 Billion 23.23 Billion 23.74 Billion 23.19 Billion 23.25 Billion
Intangible Assets 8.81 Billion 10.45 Billion 12.73 Billion 14.78 Billion 17.02 Billion 18.94 Billion
Long-Term Investments 799 Million 766 Million 816 Million 821 Million 883 Million 897 Million
Tax Assets - 6.03 Billion 5.21 Billion 3.72 Billion 3.07 Billion 1.86 Billion
Other Non Current Assets 7.09 Billion - - - - 17 Million
Other Assets - - - - - -
Total Liabilities 34.38 Billion 37.53 Billion 39.17 Billion 39.54 Billion 36.58 Billion 36.45 Billion
Total Current Liabilities 13.84 Billion 15.48 Billion 13.1 Billion 11.9 Billion 10.86 Billion 9.01 Billion
Account Payables 4.29 Billion 4.6 Billion 4.4 Billion 3.94 Billion 3.25 Billion 2.97 Billion
Tax Payables 492 Million 343 Million 306 Million 362 Million 226 Million 305 Million
Short Term Debt 1.08 Billion 2.25 Billion 754 Million 220 Million 1.47 Billion 207 Million
Deferred Revenue -1.08 Billion - - - - 305 Million
Other Current Liabilities 9.54 Billion 8.63 Billion 7.94 Billion 7.74 Billion 6.13 Billion 5.52 Billion
Total Non Current Liabilities 20.54 Billion 22.04 Billion 26.06 Billion 27.63 Billion 25.72 Billion 27.43 Billion
Long-Term Debt 14.54 Billion 15.46 Billion 18.25 Billion 19.42 Billion 17.41 Billion 19.35 Billion
Deferred Revenue Non Current 1.96 Billion - 2.73 Billion 3.11 Billion 2.81 Billion 2.04 Billion
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 3.46 Billion 5.58 Billion 3.68 Billion 3.68 Billion 3.94 Billion 3.98 Billion
Other Liabilities - - - - - -
Total Equity 38.82 Billion 36.9 Billion 36.02 Billion 33 Billion 31.3 Billion 30.72 Billion
Stock Holders Equity 38.6 Billion 36.68 Billion 35.8 Billion 32.78 Billion 31.08 Billion 30.52 Billion
Common Stock 24.86 Billion 24.7 Billion 24.47 Billion 24.14 Billion 23.85 Billion 23.51 Billion
Retained Earnings 37.55 Billion 35.25 Billion 31.52 Billion 27.62 Billion 25.84 Billion 24.56 Billion
Accumulated other comprehensive income -7.83 Billion -8.05 Billion -8.37 Billion -8.94 Billion -8.46 Billion -7.58 Billion
Common Stock Equity 38.6 Billion 36.68 Billion 35.8 Billion 32.78 Billion 31.08 Billion 30.52 Billion
Capital Lease Obligation 949 Million 943 Million 956 Million 902 Million 755 Million -
Total Investments 868 Million 1.05 Billion 1.26 Billion 1.13 Billion 1.16 Billion 1.13 Billion
Total Debt 15.62 Billion 17.71 Billion 19 Billion 19.64 Billion 18.89 Billion 19.56 Billion
Net Debt 8.73 Billion 7.83 Billion 9.2 Billion 12.81 Billion 15.03 Billion 15.72 Billion

Balance Sheet Charts